UnitedHealth Group Inc. (NYSE:UNH) issued an update on its FY14 earnings guidance on Thursday morning. The company provided EPS guidance of $5.40-5.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.59, ARN reports. UnitedHealth Group Inc. (NYSE:UNH) shares after opening at $75.44 moved to $76.65 on last trade day and at the end of the day closed at $75.78. Company price to sales ratio in past twelve months was calculated as 0.61 and price to cash ratio as 10.30. UnitedHealth Group Inc. (NYSE:UNH) showed a negative weekly performance of -5.26%.
Stock analysts at Susquehanna boosted their target price on shares of Aetna Inc (NYSE:AET) from $80.00 to $85.00 in a report issued on Thursday, American Banking and Market News reports. The firm currently has a “positive” rating on the stock. Aetna Inc (NYSE:AET) shares fell -3.01% in last trading session and ended the day on $67.77. AET return on equity ratio is recorded as 14.80% and its return on assets is 4.00%. Aetna Inc (NYSE:AET) yearly performance is 26.65%.
Repligen Corporation (NASDAQ:RGEN) replaced Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) in the S&P SmallCap 600 after the close of trading on Thursday, April 17. Repligen Corporation (NASDAQ:RGEN) shares moved up 2.86% in last trading session and was closed at $15.84 while trading in range of $15.22 -$16.22 – Repligen Corporation (NASDAQ:RGEN) year to date (YTD) performance is 16.13%.
Zalicus Inc (NASDAQ:ZLCS) skyrocketed 31.07% after the company announced that it has entered into a definitive agreement with Epirus Biopharmaceuticals, Inc. under which Epirus will merge with a wholly-owned subsidiary of Zalicus in an all-stock transaction. Zalicus Inc (NASDAQ:ZLCS) on last trading day company shares ended up $1.21. Zalicus Inc (NASDAQ:ZLCS) distance from 50-day simple moving average (SMA50) is -11.16%. Analysts mean target price for the company is $1.20.